[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myomo Inc (MYO)

Myomo Inc (MYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,653
  • Shares Outstanding, K 38,512
  • Annual Sales, $ 40,930 K
  • Annual Income, $ -15,570 K
  • EBIT $ -14 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.39
  • Price/Sales 0.81
  • Price/Cash Flow N/A
  • Price/Book 2.90
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings $-0.08 on 03/09/26
  • Next Earnings Date 05/06/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Options Overview Details

View History
  • Implied Volatility 319.12% (-4.71%)
  • Historical Volatility 72.48%
  • IV Percentile 61%
  • IV Rank 20.93%
  • IV High 1,273.78% on 09/18/25
  • IV Low 66.41% on 06/27/25
  • Expected Move (DTE 11) 0.1190 (13.84%)
  • Put/Call Vol Ratio 0.10
  • Today's Volume 111
  • Volume Avg (30-Day) 195
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 6,104
  • Open Int (30-Day) 4,621
  • Expected Range 0.7410 to 0.9790

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.12
  • Number of Estimates 2
  • High Estimate $-0.11
  • Low Estimate $-0.12
  • Prior Year $-0.08
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6531 +32.11%
on 04/07/26
0.9500 -9.18%
on 04/21/26
+0.1928 (+28.78%)
since 04/02/26
3-Month
0.6050 +42.61%
on 03/31/26
0.9500 -9.18%
on 04/21/26
+0.0528 (+6.52%)
since 02/04/26
52-Week
0.6050 +42.61%
on 03/31/26
4.8900 -82.36%
on 05/05/25
-4.0172 (-82.32%)
since 05/02/25

Most Recent Stories

More News
Myomo Announces Availability of MyoPro at Ottobock Care Clinics in the U.S.

Myomo, Inc. (NYSE American: MYO) , a wearable medical robotics company and manufacturer of the MyoPro® powered arm brace , announces expanded access to the MyoPro...

MYO : 0.8628 (-4.11%)
Myomo to Report First Quarter 2026 Financial Results on May 7

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.8628 (-4.11%)
Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement

Myomo, Inc. (NYSE American: MYO) , a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of...

MYO : 0.8628 (-4.11%)
Myomo Appoints William J Febbo to its Board of Directors

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...

MYO : 0.8628 (-4.11%)
OPRX : 6.77 (+1.04%)
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Fourth quarter revenue of $11.4 million, full year revenue of $40.9 million 42% of fourth quarter revenue from recurring patient sources ...

MYO : 0.8628 (-4.11%)
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.8628 (-4.11%)
Myomo to Report Fourth Quarter 2025 Financial Results on March 9

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.8628 (-4.11%)
Myomo Reports Third Quarter 2025 Financial and Operating Results

Revenue of $10.1 million 229 authorizations and orders, highest number this year Reiterates full year revenue guidance of $40 million to $42...

MYO : 0.8628 (-4.11%)
Myomo to Report Third Quarter 2025 Financial Results on November 10

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.8628 (-4.11%)
Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.8628 (-4.11%)

Business Summary

Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed...

See More

Key Turning Points

3rd Resistance Point 0.9465
2nd Resistance Point 0.9235
1st Resistance Point 0.8932
Last Price 0.8628
1st Support Level 0.8399
2nd Support Level 0.8169
3rd Support Level 0.7866

See More

52-Week High 4.8900
Fibonacci 61.8% 3.2531
Fibonacci 50% 2.7475
Fibonacci 38.2% 2.2419
Last Price 0.8628
52-Week Low 0.6050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.